Open AccessPharmaceutical Industry–Initiated Postapproval Studies—Not Requested by the US FDA, Little Value, and Many Questions
Author(s) -
Joel Lexchin
Publication year - 2019
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2019.3392
Subject(s) - postmarketing surveillance , pharmaceutical industry , clinical trial , medicine , value (mathematics) , drug industry , drug approval , business , pharmacology , adverse effect , engineering , drug , computer science , engineering ethics , machine learning , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom